AxoGen upgraded by Canaccord Genuity with a new price target
$AXGN
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Health Care
Canaccord Genuity upgraded AxoGen from Hold to Buy and set a new price target of $15.00 from $10.00 previously